pharmaceutical marketing

In cardiology, physician receipt of industry payments was associated with prescribing patterns for PCSK9 inhibitors, angiotensin receptor neprilysin inhibitors, and direct oral anticoagulants in an analysis from the NCDR PINNACLE registry. The direction and...

Cardiology prescribing of PCSK9 inhibitors, ARNi, and DOACs was examined by linking the NCDR PINNACLE registry with the Open Payments program. Payments to physicians correlated with higher use of these newer, higher-cost therapies, with associations varying...

Pharmaceutical marketing and physician payments were associated with higher prescribing of PCSK9 inhibitors, ARNi, and DOACs within a national outpatient cardiology registry. Patterns linked even modest transfers of value to greater use of high-cost therapi...